The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Ton Slagboom
Showing 1-16 of 16 articles
Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent – five-year results of the TARGET All Comers randomised clinical trial
Lansky AJ,
Xu B,
Baumbach A,
Kelbæk H,
van Royen N,
Zheng M,
Knaapen P,
Slagboom T,
Johnson TW,
Vlachojannis GJ,
Arkenbout KE,
Holmvang L,
Janssens L,
Brugaletta S,
Naber CK,
Schmitz T,
Anderson R,
Rittger H,
Berti S,
Barbato E,
Toth GG,
Maillard L,
Valina CM,
Buszman PE,
Thiele H,
Schächinger V,
Wijns W
December 4, 2023 | 10.4244/EIJ-D-23-00409
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial
Slagboom T,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Ruiz Salmeron R,
Witkowski A,
Uematus M,
Takahashi A,
Waksman R,
Saito S
February 20, 2023 | 10.4244/EIJ-D-22-00526
BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months
Saito S,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Ruiz Salmeron R,
Witkowski A,
Uematsu M,
Takahashi A,
Waksman R,
Slagboom T
December 6, 2019 | 10.4244/EIJ-D-18-01214
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET All Comers
Baumbach A,
Lansky AJ,
Onuma Y,
Asano T,
Johnson TW,
Anderson R,
Kiemeneij F,
Zeng M,
van Royen N,
Slagboom T,
Vlachojannis GJ,
Serruys P,
Wijns W
November 20, 2018 | 10.4244/EIJ-D-18-00226
Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials
Wijns W,
Vrolix M,
Verheye S,
Schoors D,
Slagboom T,
Gosselink M,
Benit E,
Kandzar D,
Donohoe D,
Ormiston J
April 6, 2018 | 10.4244/EIJ-D-17-00230
Direct implantation of rapamycin-eluting stents with bioresorbable drug carrier technology utilising the Svelte coronary stent-on-a-wire: the DIRECT II study
Verheye S,
Khattab A,
Carrié D,
Stella P,
Slagboom T,
Bartunek J,
Onuma Y,
Serruys P
August 5, 2016 | 10.4244/EIJV12I5A101
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
Vlachojannis GJ,
Smits PC,
Hofma S,
Togni M,
Vázquez N,
Valdes M,
Voudris V,
Puricel S,
Slagboom T,
Goy J-J,
den Heijer P,
van der Ent M
July 20, 2015 | 10.4244/EIJV11I3A53
Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial
Wijns W,
Vrolix M,
Verheye S,
Schoors D,
Slagboom T,
Gosselink M,
Benit E,
Donohoe D,
Knape C,
Attizzani G,
Lansky AJ,
Ormiston J
April 20, 2015 | 10.4244/EIJY14M05_03
Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study
Vos N,
Dirksen M,
Vink M,
van Nooijen F,
Amoroso G,
Herrman JP,
Kiemeneij F,
Patterson M,
Slagboom T,
van der Schaaf R
September 28, 2014 | 10.4244/EIJV10I5A101
Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry
Toelg R,
Merkely B,
Erglis A,
Hoffmann S,
Bruno H,
Kornowski R,
Slagboom T,
Naber CK,
Witzenbichler B,
Graf K,
Richardt G,
Hehrlein C
September 28, 2014 | 10.4244/EIJV10I5A102
Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II)
Teeuwen K,
Van den Branden B,
Rahel B,
Laarman G,
Thijssen J,
Kelder J,
Slagboom T,
ten Berg JM,
Suttorp MJ
June 28, 2013 | 10.4244/EIJV9I2A36
Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study)
Van den Branden B,
Rahel B,
Laarman G,
Slagboom T,
Kelder J,
ten Berg JM,
Suttorp MJ
February 21, 2012 | 10.4244/EIJV7I10A190
Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial
Silber S,
Gutiérrez-Chico J-L,
Behrens S,
Witzenbichler B,
Wiemer M,
Hoffmann S,
Slagboom T,
Harald D,
Suryapranata H,
Nienaber C,
Naber CK,
Chevalier B,
Serruys P
May 17, 2011 | 10.4244/EIJV7I1A13
Magnetically navigated percutaneous coronary intervention in distal and/or complex lesions may improve procedural outcome and material consumption
IJsselmuiden AJ,
Patterson M,
van Nooijen F,
Tangelder G-J,
Dirksen M,
Amoroso G,
Slagboom T,
Serruys P,
Laarman GJ,
Kiemeneij F
January 20, 2009
Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study
Dirksen M,
Vink M,
Suttorp MJ,
Thijssen J,
Patterson M,
Slagboom T,
Kiemeneij F,
Laarman GJ
May 13, 2008
Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD
Serruys P,
Vranckx P,
Slagboom T,
Regar E,
Meliga E,
de Winter R,
Heyndrickx G,
Schuler G,
van Remortel E,
Dubé GP,
Symons J
March 20, 2008
1
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023